
SRZN
(NASDAQ)Surrozen, Inc.
$23.96-- (--)
Loading... - Market loading
Surrozen (SRZN) Stock Price & Financial Analysis
Surrozen Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Day's Range$22.84 - $24.95
52-Week High$35.00
52-Week Low$9.55
Open$23.84
Volume212.87K
Average Volume (3M)244.44K
Market Cap264.86M
Shares Outstanding10.95M
Price to Sales (P/S)37.43
Price to Book (P/B)-1.01
EV/EBITDA-1.63
Revenue (TTM)7.49M
Net Income (TTM)-342.56M
Free Cash Flow (TTM)-33.68M
EPS (TTM)$-36.87
Profit Margin-4571.14%
Operating Margin-573.75%
50-Day MA$22.93
200-Day MA$23.09
52-Week Change167.99%
Annual Dividend$0.00
Dividend Yield0.00%
Day's Range$22.84 - $24.95
52-Week High$35.00
52-Week Low$9.55
Open$23.84
Volume212.87K
Average Volume (3M)244.44K
Market Cap264.86M
Shares Outstanding10.95M
Price to Sales (P/S)37.43
Price to Book (P/B)-1.01
EV/EBITDA-1.63
Revenue (TTM)7.49M
Net Income (TTM)-342.56M
Free Cash Flow (TTM)-33.68M
EPS (TTM)$-36.87
Profit Margin-4571.14%
Operating Margin-573.75%
50-Day MA$22.93
200-Day MA$23.09
52-Week Change167.99%
Annual Dividend$0.00
Dividend Yield0.00%
Frequently Asked Questions About Surrozen
What is the current stock price for SRZN?
As of the latest trading session, SRZN stock trades at $23.96. The 52-week range is $9.55–$35.00, with a day range of $22.84–$24.95.
What is the P/E ratio for SRZN?
The P/E ratio (Price-to-Earnings) for SRZN is shown in the Key Statistics section. This valuation metric helps compare Surrozen, Inc. to industry peers.
Does SRZN pay dividends?
Surrozen does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for SRZN?
Based on 1 analyst, the consensus for SRZN is Buy.
What is the market cap of SRZN?
Surrozen's market capitalization is $262.3M, classifying it as a micro-cap company. Surrozen operates in the Healthcare sector within the Biotechnology industry.